Empire Genomics’ Post

Big Things Happening at the Precision Medicine Initiative & Grafton Clinical Genomics (Jason Copedo)! 🔍 Mystery Crate Alert! 📦 Jason Copedo and I just received a huge wooden crate! It's not just big in size, but big in impact too. We're on the brink of a major leap in genomics. Get ready for a year of new capabilities with us. What's inside the box? Stay tuned for the big reveal!🧬🧬🧬 #PrecisionMedicine #ClinicalGenomics #Innovation #GraftonClinicalGenomics

#PAP2023Lahore: Attending a workshop on the future of sequencing applications for clinical diagnosis can provide valuable insights into emerging technologies, methodologies, and advancements in genomics. Stay updated on the latest trends, diagnostic tools, and personalized medicine approaches, enhancing your understanding of how sequencing can revolutionize clinical diagnosis. Don't miss the opportunity to engage with experts, exchange ideas, and explore the potential applications that could shape the future of healthcare

Come hear the latest updates on our work with genomic labs and EHRs to help standardize the exchange of genomic test results!

The Power of Genomic Data in Precision Medicine Genomic data is the cornerstone of precision medicine, offering insights that enable personalized treatments. Dive into our latest article to understand the value, acquisition, and analysis of genomic data. Make informed investment decisions in this transformative field. 🧬💡 #GenomicData #PrecisionMedicine #HealthTechInvesting https://lnkd.in/g69a33Tz

I will talk about what #RealWorldData from #Aging Research Can Teach Us for #AI-based #PrecisionMedicine in #Drug Development" at the 15th Drug Discovery Innovation Forum. Among other papers I will discuss a Nature paper from last year: "Heterogeneous #aging across multiple #organ systems and prediction of chronic #disease and #mortality[1]" From the abstract: ➡"Biological aging of human #organ systems reflects the interplay of age, #chronicdisease, #lifestyle and #genetic risk. Using longitudinal #brainimaging and physiological phenotypes from the UK Biobank, we establish normative models of biological age for three brain and seven body systems. ➡Here we find that an organ’s biological age selectively influences the aging of other organ systems, revealing a multiorgan aging network. ➡We report organ age profiles for 16 chronic diseases, where advanced biological aging extends from the organ of primary disease to multiple systems. Advanced body age associates with several lifestyle and environmental factors, leukocyte telomere lengths and mortality risk, and predicts survival time (area under the curve of 0.77) and premature death (area under the curve of 0.86). Our work reveals the multisystem nature of human aging in health and chronic disease. It may enable early identification of individuals at increased risk of aging-related morbidity and inform new strategies to potentially limit organ-specific aging in such individuals." [1]Tian, Y.E., Cropley, V., Maier, A.B. et al. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med 29, 1221–1231 (2023).

Conscience open science model is revolutionizing the drug discovery process. This model sparks collaboration between companies, researchers and academics, in contrast to the patent-driven model where scientists work alone. An open and transparent exchange of data makes the drug-discovery process faster and more affordable. #ICYMI: Conscience’s first open science competition yielded a promising discovery that could lead to better treatments for Parkinson’s Disease. Learn more: https://conscience.ca/ #LoveData24 #OpenScience

With every innovation in #MassSpec, we are pushing science and precision medicine forward. This article in [@LCGC] explores the significance of the #OrbitrapAstralMS and the ways in which it offers researchers the ability to study #proteomics and #metabolomics cohorts on a larger scale – paving the way for a more personalized approach to healthcare. Read more here:

How can #digitaltwins transform #healthcare? This question will be discussed at the First International Symposium on Digital Twins in Healthcare with MunichImaging coordinated #OPTOMICS #HorizonEurope project and the projects #DIGIPREDICT, #Neurotwin, and #EDITH_CSA There are several plenary speakers from #Optomics: Vasilis Ntziachristos from MunichImaging, Eleftheria Zeggini at Helmholtz Munich, Anne Demoisy at Rizome s.a. and Ivy Curren from MunichImaging in the panel discussion. Learn more about the symposium held from 16-17. May in Cypress here: https://lnkd.in/djKDZNJ2 Digital Twins are driving a revolution in human model development by leveraging data from multi-#omics analyses, #medical and #imaging data, environmental and life style #bigdata that are continuously updated by a multitude of biosensors at an unprecedented scale. Helmholtz Munich Technical University of Munich European Innovation Council and SMEs Executive Agency (EISMEA)

Welcome to bleepDigital - the community that examines illnesses related to #digital technologies. From runaway insulin pumps, to #VR induced seizures, we highlight syndromes that begin in #technology & end in biology. Join our network for the latest cases: https://lnkd.in/e_ZSc83Z . . . . . #AIEthics #Bioethics #MedicalAI #AI #AIBias #Algorithms #AlgorithmicBias #AlgorithmicEquity #PublicHealth #HealthInequalities #MedTech #DigitalHealth #MedicalDevices #MedicalTechnology #MedicalCybersecurity #Biotech #BiotechSyndromes #Biotechnology

Discover the cutting-edge ways technology drives the life sciences industry forward – from accelerating R&D with digital biomarkers, and early disease progression or decentralized trials to informing earlier diagnoses.  In this session, moderated by Elisabetta Ravot, Ph.D. from Healthware Group, you will hear from key leaders on the following topics: - Multi-modal generative AI and robotics for drug discovery and development and aging research - Alex Zhavoronkov, Insilico Medicine  - Designing DNA to discover new medicines - Sidhyansh Saxena, Ginkgo Bioworks, Inc. Bioworks - AI without boundaries - Alessandro De Luca, Merck  - Catalyzing research and innovation - Ryan J. Bate, Kelly Gray, Peter Fenici, AstraZeneca - Accelerating R&D with Patient-Centric Real World Data - ⬥ Ardy Arianpour ⬥ Arianpour, SEQSTER - Insights from the Frontlines: Decentralized Trials and Post-Pandemic Innovations - Eugene Borukhovich, YourCoach.Health, and Meri Beckwith, Lindus Health - Innovation in the methodology of R&D - Moderated by Elena Pirofalo, Healthware Group with: Fran Antequera, ATG Synbio Spain; Laura-Joy Boulos, PhD, Globivest | Sci-dip Riccardo Mariani, Chiesi Group; Dorothy Zhang, iGEM More details on this thematic session here: https://lnkd.in/d7vdU3VE.  #FH23 #innovation #trials #RD #medicine #healthcare #digitalbiomarkers #research